World

South Korea says to begin talks to purchase coronavirus drug remdesivir in August

South Korea has started distributing stocks of the Covid-19 treatment remdesivir which have been donated by Gilead Sciences Inc and plans to begin talks to purchase more supplies in August, its disease control agency said.

Image for Representation

South Korea has started distributing stocks of the Covid-19 treatment remdesivir which have been donated by Gilead Sciences Inc and plans to begin talks to purchase more supplies in August, its disease control agency said.

“Patients who are eligible for remdesivir are limited to severe patients with pneumonia and in need of oxygen therapy,” the Korea Centers for Disease Control and Prevention (KCDC) said in a statement.

It did not disclose how many doses have been donated by the US firm.

Gilead said on Monday it has priced remdesivir at $390 per vial in the United States and other developed countries and agreed to send nearly all of its supply of the drug to the United States over the next three months.

ALSO READ | Far from over: Coronavirus pandemic speeding up, worse yet to come, warns WHO

ÄLSO WATCH | Trump blames China for coronavirus pandemic

IndiaToday.in has plenty of useful resources that can help you better understand the coronavirus pandemic and protect yourself. Read our comprehensive guide (with information on how the virus spreads, precautions and symptoms), watch an expert debunk myths, and access our dedicated coronavirus page.
Get real-time alerts and all the news on your phone with the all-new India Today app. Download from

  • Andriod App
  • IOS App

Source link

Show More

Related Articles

Back to top button